PMID: 11925306Apr 2, 2002Paper

Metformin for weight loss in pediatric patients taking psychotropic drugs

The American Journal of Psychiatry
John A MorrisonBruce A Barton

Abstract

Metformin was assessed as a treatment for weight gain in children taking olanzapine, risperidone, quetiapine, or valproate. The subjects were 19 patients aged 10-18 years; 15 were white and four were black, and there were 12 boys and seven girls. In a 12-week open-label study, each patient received metformin, 500 mg t.i.d. Changes in weight and body mass index were evaluated by using repeated measures analysis of variance. Of the 19 patients, 15 lost weight, three gained 1.6 kg or less, and one had no change. The mean changes in weight and body mass index at 12 weeks were highly significant. Metformin merits further study as a treatment for weight gain in patients taking psychotropic medications.

Citations

Dec 5, 2002·Pharmacoepidemiology and Drug Safety
Jun 24, 2006·Wiener klinische Wochenschrift·Julia EnglChristoph Ebenbichler
Feb 7, 2004·Current Diabetes Reports·Roopa Sathyaprakash, Robert R Henry
Mar 26, 2003·Journal of Psychiatric Research·Ulrich ZimmermannThomas Pollmächer
Feb 18, 2005·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Lisa Catapano, David Castle
May 14, 2008·The Australian and New Zealand Journal of Psychiatry·Sanil Rege
Apr 17, 2008·Harvard Review of Psychiatry·Michelle C AcostaFrances R Levin
Jun 13, 2009·Journal of Child and Adolescent Psychopharmacology·Lauren ShinJean A Frazier
Mar 29, 2008·Metabolic Syndrome and Related Disorders·Trino BaptistaMaritza Martinez
Mar 5, 2004·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Natalie Rasgon, Lissy Jarvik
May 29, 2004·Clinical Nurse Specialist CNS·Barbara Harrison
Jul 30, 2005·Diabetes, Obesity & Metabolism·A J GoudieJ C G Halford
Jul 14, 2007·International Journal of Clinical Practice·A TschonerC F Ebenbichler
Feb 15, 2011·Journal of Obesity·Nikhil NihalaniJames L Megna
Nov 28, 2012·Therapeutic Advances in Endocrinology and Metabolism·Evangelos Papanastasiou
Apr 24, 2004·Annals of General Hospital Psychiatry·Kimberly D McLaren, Lauren B Marangell
May 20, 2008·CNS Drugs·Trino BaptistaSerge Beaulieu
Apr 1, 2008·Indian Journal of Psychiatry·Chittaranjan Andrade
Dec 23, 2014·Current Obesity Reports·Aviva MustLinda Bandini
Feb 20, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jiamei LianChao Deng
Jan 29, 2008·Expert Opinion on Pharmacotherapy·Nitin Gogtay, Judith Rapoport
Jan 29, 2008·Expert Opinion on Pharmacotherapy·Jeffrey R Strawn, Melissa P Delbello
Mar 30, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Salvatore Gentile
Nov 24, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Paz TorenAbraham Weizman
May 22, 2009·Medicina clínica·Alfonso Calañas-ContinenteUNKNOWN Grupo de Trabajo sobre Obesidad de la Sociedad Española de Endocrinología y Nutrición
Dec 18, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Chun-Hsin ChenMong-Liang Lu
Oct 2, 2004·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·T L SchwartzM Chilton
Oct 9, 2003·Acta Psychiatrica Scandinavica·G FaulknerK Lloyd
Jan 13, 2009·Acta Psychiatrica Scandinavica·J M Meyer, S M Stahl
Aug 8, 2007·Journal of the American Academy of Nurse Practitioners·Kelly A HardenSusan B Patton
Apr 16, 2011·International Journal of Mental Health Nursing·Andrea McCloughen, Kim Foster
Nov 11, 2011·CNS Neuroscience & Therapeutics·Nikhil NihalaniJames L Megna
Mar 23, 2011·Journal of Clinical Pharmacy and Therapeutics·Y J Lee, J H Jeong
Feb 3, 2011·British Journal of Clinical Pharmacology·Samir Kumar PraharajVinod Kumar Sinha
Jan 17, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·Alan J ZametkinSuzanne Munson
Aug 12, 2008·The American Journal of Medicine·W Victor R ViewegAnand K Pandurangi
Oct 12, 2004·Clinics in Dermatology·Yvonne Linné, Stephan Rössner
Dec 2, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Walter DeberdtAlan Breier
Feb 22, 2011·The Psychiatric Clinics of North America·Rohan Ganguli, Martin Strassnig

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Michel FlorisWalter Deberdt
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Patrizia A CavazzoniDavid B Allison
© 2022 Meta ULC. All rights reserved